Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 818

1.

Atypical MRI and Histopathological Findings in Dermoid Cyst.

Otonari-Yamamoto M, Nakajima K, Sakamoto J, Imoto K, Watanabe M, Kotaki S, Kuroda M, Matsuzaka K, Shibahara T, D Curtin H, K Goto T.

Bull Tokyo Dent Coll. 2018;59(3):207-212. doi: 10.2209/tdcpublication.2017-0044.

2.

Effects of twitch contraction induced by magnetic stimulation on expression of skeletal muscle fibrosis related genes and limited range of motion in rat.

Kubo K, Sakamoto J, Honda A, Honda Y, Kataoka H, Nakano J, Okita M.

Am J Phys Med Rehabil. 2018 Sep 12. doi: 10.1097/PHM.0000000000001042. [Epub ahead of print]

PMID:
30212378
3.

Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Eur Heart J Acute Cardiovasc Care. 2018 Sep 11:2048872618799993. doi: 10.1177/2048872618799993. [Epub ahead of print]

PMID:
30203659
4.

Anxiety and Depression among Hypertensive Outpatients in Afghanistan: A Cross-Sectional Study in Andkhoy City.

Hamrah MS, Hamrah MH, Ishii H, Suzuki S, Hamrah MH, Hamrah AE, Dahi AE, Takeshita K, Yisireyili M, Hamrah MH, Fotouhi A, Sakamoto J, Murohara T.

Int J Hypertens. 2018 Aug 1;2018:8560835. doi: 10.1155/2018/8560835. eCollection 2018.

5.

Woman With Pain and Deformity in Left Wrist.

Sakamoto JT, Lipman GS.

Ann Emerg Med. 2018 Sep;72(3):254-269. doi: 10.1016/j.annemergmed.2018.02.009. No abstract available.

PMID:
30144862
6.

Very long-term follow-up data of non-ischemic idiopathic dilated cardiomyopathy after beta-blocker therapy: recurrence of left ventricular dysfunction and predictive value of 123I-metaiodobenzylguanidine scintigraphy.

Nishimura S, Izumi C, Himura Y, Kuroda M, Amano M, Harita T, Nishiuchi S, Sakamoto J, Tamaki Y, Enomoto S, Miyake M, Tamura T, Kondo H, Nakagawa Y.

Heart Vessels. 2018 Aug 24. doi: 10.1007/s00380-018-1245-y. [Epub ahead of print]

PMID:
30143883
7.

A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II).

Nishikawa K, Tsuburaya A, Yoshikawa T, Kobayashi M, Kawada J, Fukushima R, Matsui T, Tanabe K, Yamaguchi K, Yoshino S, Takahashi M, Hirabayashi N, Sato S, Nemoto H, Rino Y, Nakajima J, Aoyama T, Miyagi Y, Oriuchi N, Yamaguchi K, Miyashita Y, Morita S, Sakamoto J.

Eur J Cancer. 2018 Sep;101:220-228. doi: 10.1016/j.ejca.2018.06.026. Epub 2018 Aug 7.

PMID:
30096702
8.

Production and transplantation of bioengineered lung into a large-animal model.

Nichols JE, La Francesca S, Niles JA, Vega SP, Argueta LB, Frank L, Christiani DC, Pyles RB, Himes BE, Zhang R, Li S, Sakamoto J, Rhudy J, Hendricks G, Begarani F, Liu X, Patrikeev I, Pal R, Usheva E, Vargas G, Miller A, Woodson L, Wacher A, Grimaldo M, Weaver D, Mlcak R, Cortiella J.

Sci Transl Med. 2018 Aug 1;10(452). pii: eaao3926. doi: 10.1126/scitranslmed.aao3926.

PMID:
30068570
9.

A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.

Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Sudo T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.

Cancer Med. 2018 Sep;7(9):4217-4227. doi: 10.1002/cam4.1623. Epub 2018 Jul 26.

10.

Changes in penile length after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy.

Kadono Y, Nohara T, Kawaguchi S, Sakamoto J, Makino T, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

Andrology. 2018 Jul 2. doi: 10.1111/andr.12517. [Epub ahead of print]

PMID:
29968337
11.

Left ventricular hypertrophy and proteinuria in patients with essential hypertension in Andkhoy, Afghanistan.

Shoaib Hamrah M, Hassan Hamrah M, Ishii H, Suzuki S, Hussain Hamrah M, Edris Hamrah A, Elias Dahi A, Yisireyili M, Kano N, Takeshita K, Hashem Hamrah M, Sakamoto J, Murohara T.

Nagoya J Med Sci. 2018 May;80(2):249-255. doi: 10.18999/nagjms.80.2.249.

12.

Inadequate water treatment quality as assessed by protozoa removal in Sarawak, Malaysia.

Ting Lo N, Abul Bashar Sarker M, Ai Lian Lim Y, Harun-Or-Rashid M, Sakamoto J.

Nagoya J Med Sci. 2018 May;80(2):165-174. doi: 10.18999/nagjms.80.2.165.

13.

Investigating the viral ecology of global bee communities with high-throughput metagenomics.

Galbraith DA, Fuller ZL, Ray AM, Brockmann A, Frazier M, Gikungu MW, Martinez JFI, Kapheim KM, Kerby JT, Kocher SD, Losyev O, Muli E, Patch HM, Rosa C, Sakamoto JM, Stanley S, Vaudo AD, Grozinger CM.

Sci Rep. 2018 Jun 11;8(1):8879. doi: 10.1038/s41598-018-27164-z.

14.

Potential biological control of Erwinia tracheiphila by internal alimentary canal interactions in Acalymma vittatum with Pseudomonas fluorescens.

Roberts DC, Fleischer SJ, Sakamoto JM, Rasgon JL.

J Appl Microbiol. 2018 Oct;125(4):1137-1146. doi: 10.1111/jam.13950. Epub 2018 Jul 26.

PMID:
29890026
15.

Effects of Exercise Training Combined with Increased Physical Activity to Prevent Chronic Pain in Community-Dwelling Older Adults: A Preliminary Randomized Controlled Trial.

Hirase T, Kataoka H, Inokuchi S, Nakano J, Sakamoto J, Okita M.

Pain Res Manag. 2018 Apr 5;2018:2132039. doi: 10.1155/2018/2132039. eCollection 2018.

16.

Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.

Mizuta S, Sawa M, Tsurumi H, Matsumoto K, Miyao K, Hara T, Takahashi T, Sakemura R, Kojima H, Kohno A, Oba MS, Morita S, Sakamoto J, Emi N.

Int J Clin Oncol. 2018 May 29. doi: 10.1007/s10147-018-1300-9. [Epub ahead of print]

PMID:
29845477
17.

The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).

Nishikawa K, Aoyama T, Oba MS, Yoshikawa T, Matsuda C, Munemoto Y, Takiguchi N, Tanabe K, Nagata N, Imano M, Oshiro M, Fukushima R, Kataoka M, Morita S, Tsuburaya A, Mishima H, Kono T, Sakamoto J.

J Cancer. 2018 Apr 19;9(10):1725-1730. doi: 10.7150/jca.24733. eCollection 2018.

18.

Infrared Laser-Mediated Gene Induction at the Single-Cell Level in the Regenerating Tail of Xenopus laevis Tadpoles.

Hasugata R, Hayashi S, Kawasumi-Kita A, Sakamoto J, Kamei Y, Yokoyama H.

Cold Spring Harb Protoc. 2018 May 16. doi: 10.1101/pdb.prot101014. [Epub ahead of print]

PMID:
29769391
19.

Comparable efficacy of endoscopic transpapillary gallbladder drainage and percutaneous transhepatic gallbladder drainage in acute cholecystitis.

Iino C, Shimoyama T, Igarashi T, Aihara T, Ishii K, Sakamoto J, Tono H, Fukuda S.

Endosc Int Open. 2018 May;6(5):E594-E601. doi: 10.1055/s-0044-102091. Epub 2018 May 8.

20.

Pretreatment evaluation of fluorescence resonance energy transfer-based drug sensitivity test for patients with chronic myelogenous leukemia treated with dasatinib.

Kondo T, Fujioka M, Tsuda M, Murai K, Yamaguchi K, Miyagishima T, Shindo M, Nagashima T, Wakasa K, Fujimoto N, Yamamoto S, Yonezumi M, Saito S, Sato S, Ogawa K, Chou T, Watanabe R, Kato Y, Takahashi S, Okano Y, Yamamoto J, Ohta M, Iijima H, Oba K, Kishino S, Sakamoto J, Ishida Y, Ohba Y, Teshima T; Inter-Michinoku Dasatinib Study Group (IMIDAS).

Cancer Sci. 2018 Jul;109(7):2256-2265. doi: 10.1111/cas.13625. Epub 2018 May 29.

21.

Crystal Orientation-Dependent Reactivity of Oxide Surfaces in Contact with Lithium Metal.

Connell JG, Zhu Y, Zapol P, Tepavcevic S, Sharafi A, Sakamoto J, Curtiss LA, Fong DD, Freeland JW, Markovic NM.

ACS Appl Mater Interfaces. 2018 May 23;10(20):17471-17479. doi: 10.1021/acsami.8b03078. Epub 2018 May 9.

PMID:
29708721
22.

Oral carcinoma: Clinical evaluation using diffusion kurtosis imaging and its correlation with histopathologic findings.

Yamada I, Yoshino N, Hikishima K, Sakamoto J, Yokokawa M, Oikawa Y, Harada H, Kurabayashi T, Saida Y, Tateishi U, Yukimori A, Izumo T, Asahina S.

Magn Reson Imaging. 2018 Sep;51:69-78. doi: 10.1016/j.mri.2018.04.014. Epub 2018 Apr 26.

PMID:
29704561
23.

Association between Helicobacter pylori Infection and Cardiovascular Risk Factors among Patients in the Northern Part of Afghanistan: a Cross-Sectional Study in Andkhoy City

Hamrah MS, Hamrah MH, Ishii H, Suzuki S, Hamrah MH, Hamrah AE, Dahi AE, Takeshita K, Hamrah MH, Fotouhi A, Sakamoto J, Murohara T.

Asian Pac J Cancer Prev. 2018 Apr 25;19(4):1035-1039.

24.

Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.

Kanda K, Sakamoto J, Matsumoto Y, Ikuta K, Goto N, Morita Y, Ohno M, Nishi K, Eto K, Kimura Y, Nakanishi Y, Ikegami K, Yoshikawa T, Fukuda A, Kawada K, Sakai Y, Ito A, Yoshida M, Kimura T, Chiba T, Nishi E, Seno H.

JCI Insight. 2018 Apr 19;3(8). pii: 91316. doi: 10.1172/jci.insight.91316. [Epub ahead of print]

25.

A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study.

Matsuda C, Honda M, Tanaka C, Kondo K, Takahashi T, Kosugi C, Tokunaga Y, Takemoto H, Kim HM, Sakamoto J, Oba K, Mishima H.

Cancer Chemother Pharmacol. 2018 Jun;81(6):1035-1041. doi: 10.1007/s00280-018-3568-x. Epub 2018 Apr 11.

PMID:
29644459
26.

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment.

Okada M, Imagawa J, Tanaka H, Nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, Akasaka H, Utsumi T, Uike N, Sato T, Ando S, Usuki K, Mizuta S, Hashino S, Nomura T, Shikami M, Fukutani H, Ohe Y, Kosugi H, Shibayama H, Maeda Y, Fukushima T, Yamazaki H, Tsubaki K, Kukita T, Adachi Y, Nataduka T, Sakoda H, Yokoyama H, Okamoto T, Shirasugi Y, Onishi Y, Nohgawa M, Yoshihara S, Morita S, Sakamoto J, Kimura S; DADI Trial Group, Japan.

Clin Lymphoma Myeloma Leuk. 2018 May;18(5):353-360.e1. doi: 10.1016/j.clml.2018.03.004. Epub 2018 Mar 15.

27.

Colorectal carcinoma: Ex vivo evaluation using q-space imaging; Correlation with histopathologic findings.

Yamada I, Hikishima K, Yoshino N, Sakamoto J, Miyasaka N, Yamauchi S, Uetake H, Yasuno M, Saida Y, Tateishi U, Kobayashi D, Eishi Y.

J Magn Reson Imaging. 2018 Mar 30. doi: 10.1002/jmri.26018. [Epub ahead of print]

PMID:
29601149
28.

Impact of frailty on chronic pain, activities of daily living and physical activity in community-dwelling older adults: A cross-sectional study.

Hirase T, Kataoka H, Nakano J, Inokuchi S, Sakamoto J, Okita M.

Geriatr Gerontol Int. 2018 Jul;18(7):1079-1084. doi: 10.1111/ggi.13314. Epub 2018 Mar 26.

PMID:
29582534
29.

Anatomical study of the articular branches innervated the hip and knee joint with reference to mechanism of referral pain in hip joint disease patients.

Sakamoto J, Manabe Y, Oyamada J, Kataoka H, Nakano J, Saiki K, Okamoto K, Tsurumoto T, Okita M.

Clin Anat. 2018 Jul;31(5):705-709. doi: 10.1002/ca.23077. Epub 2018 Apr 16.

PMID:
29577432
30.

Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Konishi T, Akao M, Kobayashi Y, Inoue T, Oi M, Izumi T, Takahashi K, Tada T, Chen PM, Murata K, Tsuyuki Y, Sakai H, Saga S, Sasa T, Sakamoto J, Yamada C, Kinoshita M, Togi K, Ikeda T, Ishii K, Kaneda K, Mabuchi H, Otani H, Takabayashi K, Takahashi M, Shiomi H, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Circ J. 2018 Apr 25;82(5):1262-1270. doi: 10.1253/circj.CJ-17-1128. Epub 2018 Mar 23.

31.

Bombesin receptor subtype-3-expressing neurons regulate energy homeostasis through a novel neuronal pathway in the hypothalamus.

Maruyama M, Hotta N, Nio Y, Hamagami K, Nagi T, Funata M, Sakamoto J, Nakakariya M, Amano N, Nishida M, Okawa T, Arikawa Y, Sasaki S, Kasai S, Nagisa Y, Habata Y, Mori M.

Brain Behav. 2017 Dec 15;8(1):e00881. doi: 10.1002/brb3.881. eCollection 2018 Jan.

32.

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.

Mayanagi S, Kashiwabara K, Honda M, Oba K, Aoyama T, Kanda M, Maeda H, Hamada C, Sadahiro S, Sakamoto J, Saji S, Yoshikawa T.

Dis Colon Rectum. 2018 Jul;61(7):803-808. doi: 10.1097/DCR.0000000000001002.

33.

Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.

Xu RH, Muro K, Morita S, Iwasa S, Han SW, Wang W, Kotaka M, Nakamura M, Ahn JB, Deng YH, Kato T, Cho SH, Ba Y, Matsuoka H, Lee KW, Zhang T, Yamada Y, Sakamoto J, Park YS, Kim TW.

Lancet Oncol. 2018 May;19(5):660-671. doi: 10.1016/S1470-2045(18)30140-2. Epub 2018 Mar 16.

PMID:
29555258
34.

Are Nonpharmacologic Pain Interventions Effective at Reducing Pain in Adult Patients Visiting the Emergency Department? A Systematic Review and Meta-analysis.

Sakamoto JT, Ward HB, Vissoci JRN, Eucker SA.

Acad Emerg Med. 2018 Mar 15. doi: 10.1111/acem.13411. [Epub ahead of print] Review.

PMID:
29543359
35.

A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial.

Takahashi N, Kanda M, Yoshikawa T, Takiguchi N, Fujitani K, Miyamoto K, Ito Y, Takayama O, Imano M, Mitsumori N, Sakamoto J, Morita S, Kodera Y.

Gastric Cancer. 2018 Mar 13. doi: 10.1007/s10120-018-0817-y. [Epub ahead of print]

PMID:
29536296
36.

Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials.

Kanda M, Oba K, Aoyama T, Kashiwabara K, Mayanagi S, Maeda H, Honda M, Hamada C, Sadahiro S, Sakamoto J, Saji S, Yoshikawa T; Japanese Foundation for Multidisciplinary Treatment of Cancer.

Dis Colon Rectum. 2018 Apr;61(4):461-471. doi: 10.1097/DCR.0000000000001022.

PMID:
29521828
37.

A phase II trial to evaluate the efficacy of panitumumab combined with fluorouracil-based chemotherapy for metastatic colorectal cancer: the PF trial.

Munemoto Y, Kanda M, Oba K, Kim HM, Takemoto H, Denda T, Nagata N, Takano N, Fukunaga M, Kataoka M, Tokunaga Y, Sakamoto J, Mishima H.

Cancer Chemother Pharmacol. 2018 May;81(5):829-838. doi: 10.1007/s00280-018-3556-1. Epub 2018 Mar 5.

PMID:
29508026
38.

A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.

Toyooka S, Okumura N, Nakamura H, Nakata M, Yamashita M, Tada H, Kajiwara S, Watanabe N, Okada M, Sakamoto J, Aoe M, Soh J, Miyoshi S, Hotta K, Matsuo K, Date H.

J Thorac Oncol. 2018 May;13(5):699-706. doi: 10.1016/j.jtho.2018.02.015. Epub 2018 Mar 2.

PMID:
29505900
39.

A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.

Nishikawa K, Tsuburaya A, Yoshikawa T, Takahashi M, Tanabe K, Yamaguchi K, Yoshino S, Namikawa T, Aoyama T, Rino Y, Kawada J, Tsuji A, Taira K, Kimura Y, Kodera Y, Hirashima Y, Yabusaki H, Hirabayashi N, Fujitani K, Miyashita Y, Morita S, Sakamoto J.

Gastric Cancer. 2018 Sep;21(5):811-818. doi: 10.1007/s10120-018-0815-0. Epub 2018 Feb 27.

PMID:
29488122
40.

Effects of Warm Versus Cold Ischemic Donor Lung Preservation on the Underlying Mechanisms of Injuries During Ischemia and Reperfusion.

Iskender I, Cypel M, Martinu T, Chen M, Sakamoto J, Kim H, Yu K, Lin H, Guan Z, Hashimoto K, Waddell TK, Liu M, Keshavjee S.

Transplantation. 2018 May;102(5):760-768. doi: 10.1097/TP.0000000000002140.

PMID:
29470355
41.

Usefulness of the maximum standardized uptake value for the diagnosis and staging of patients with cervical cancer undergoing positron emission tomography/computed tomography.

Takagi H, Sakamoto J, Osaka Y, Shibata T, Fujita S, Sasagawa T.

Medicine (Baltimore). 2018 Feb;97(7):e9856. doi: 10.1097/MD.0000000000009856.

42.

Microstructure and in vivo characterization of multi-channel nerve guidance scaffolds.

Pawelec KM, Koffler J, Shahriari D, Galvan A, Tuszynski MH, Sakamoto J.

Biomed Mater. 2018 Apr 25;13(4):044104. doi: 10.1088/1748-605X/aaad85.

PMID:
29411711
43.

Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response-The final results of the D-first study.

Najima Y, Yoshida C, Iriyama N, Fujisawa S, Wakita H, Chiba S, Okamoto S, Kawakami K, Takezako N, Kumagai T, Ohyashiki K, Taguchi J, Yano S, Igarashi T, Kouzai Y, Morita S, Sakamoto J, Sakamaki H, Inokuchi K.

Leuk Res. 2018 Mar;66:66-72. doi: 10.1016/j.leukres.2018.01.010. Epub 2018 Feb 3.

PMID:
29407585
44.

Utility of 18F-fluorodeoxyglucose-positron emission tomography in the differential diagnosis of benign and malignant gynaecological tumours.

Takagi H, Sakamoto J, Osaka Y, Shibata T, Fujita S, Sasagawa T.

J Med Imaging Radiat Oncol. 2018 Feb 5. doi: 10.1111/1754-9485.12707. [Epub ahead of print]

PMID:
29399968
45.

Meta-analysis of randomized clinical trials in the era of individual patient data sharing.

Kawahara T, Fukuda M, Oba K, Sakamoto J, Buyse M.

Int J Clin Oncol. 2018 Jun;23(3):403-409. doi: 10.1007/s10147-018-1237-z. Epub 2018 Jan 12.

46.

WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies.

Oji Y, Inoue M, Takeda Y, Hosen N, Shintani Y, Kawakami M, Harada T, Murakami Y, Iwai M, Fukuda M, Nishida S, Nakata J, Nakae Y, Takashima S, Shirakata T, Nakajima H, Hasegawa K, Kida H, Kijima T, Morimoto S, Fujiki F, Tsuboi A, Morii E, Morita S, Sakamoto J, Kumanogoh A, Oka Y, Okumura M, Sugiyama H.

Int J Cancer. 2018 Jun 1;142(11):2375-2382. doi: 10.1002/ijc.31253. Epub 2018 Jan 21.

PMID:
29322496
47.

Validity of the Pre-endoscopic Scoring Systems for the Prediction of the Failure of Endoscopic Hemostasis in Bleeding Gastroduodenal Peptic Ulcers.

Iino C, Shimoyama T, Igarashi T, Aihara T, Ishii K, Sakamoto J, Tono H, Fukuda S.

Intern Med. 2018 May 15;57(10):1355-1360. doi: 10.2169/internalmedicine.9267-17. Epub 2018 Jan 11.

48.

Comparison of the digene hybrid capture 2 and Roche cobas 4800 HPV tests for detection of CIN2+ in a referral population in Japan.

Sasagawa T, Maehama T, Osaka Y, Sakamoto J, Shibata T, Fujita S, Takakura M, Takagi H.

J Med Virol. 2018 May;90(5):972-980. doi: 10.1002/jmv.25025. Epub 2018 Jan 31.

PMID:
29315626
49.

Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface.

Sameshima T, Yamamoto T, Sano O, Sogabe S, Igaki S, Sakamoto K, Ida K, Gotou M, Imaeda Y, Sakamoto J, Miyahisa I.

Biochemistry. 2018 Feb 27;57(8):1369-1379. doi: 10.1021/acs.biochem.7b00732. Epub 2018 Feb 7.

PMID:
29293322
50.

Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives.

Niida A, Kanematsu-Yamaki Y, Asakawa T, Ishimura Y, Fujita H, Matsumiya K, Nishizawa N, Adachi Y, Mochida T, Tsuchimori K, Yoneyama-Hirozane M, Sakamoto J, Hirabayashi H, Fukui H, Takekawa S, Asami T.

Bioorg Med Chem. 2018 Feb 1;26(3):566-572. doi: 10.1016/j.bmc.2017.12.014. Epub 2017 Dec 8.

PMID:
29279243

Supplemental Content

Loading ...
Support Center